These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 8895983

  • 1. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC, Conti CJ.
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Two-stage tumor promotion in mouse skin: an alternative interpretation.
    Hennings H, Yuspa SH.
    J Natl Cancer Inst; 1985 Apr; 74(4):735-40. PubMed ID: 3921746
    [No Abstract] [Full Text] [Related]

  • 6. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J, Rho O, Xian W, Beltràn L.
    Prog Clin Biol Res; 1994 Apr; 387():113-38. PubMed ID: 7972243
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.
    Oncogene; 2000 Aug 31; 19(37):4243-54. PubMed ID: 10980598
    [Abstract] [Full Text] [Related]

  • 9. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
    Stern MC, Benavides F, Klingelberger EA, Conti CJ.
    Carcinogenesis; 2000 Jul 31; 21(7):1297-301. PubMed ID: 10874006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic analysis of multistage hepatocarcinogenesis.
    Poole TM, Chiaverotti TA, Carabeo RA, Drinkwater NR.
    Prog Clin Biol Res; 1996 Jul 31; 395():33-45. PubMed ID: 8895982
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
    Hennings H.
    Basic Life Sci; 1991 Jul 31; 57():31-9; discussion 39-42. PubMed ID: 1814291
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
    Hennings H, Devor D, Wenk ML, Slaga TJ, Former B, Colburn NH, Bowden GT, Elgjo K, Yuspa SH.
    Cancer Res; 1981 Mar 31; 41(3):773-9. PubMed ID: 6780187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K, Beltrán L, Rupp T, DiGiovanni J.
    Mol Carcinog; 1998 Jun 31; 22(2):73-83. PubMed ID: 9655251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.